Distillate Capital Partners LLC Buys Shares of 68,915 Teleflex Incorporated (NYSE:TFX)

Distillate Capital Partners LLC acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 68,915 shares of the medical technology company’s stock, valued at approximately $14,495,000. Distillate Capital Partners LLC owned approximately 0.15% of Teleflex as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in TFX. Oregon Public Employees Retirement Fund grew its position in shares of Teleflex by 1.2% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock worth $846,000 after buying an additional 46 shares during the last quarter. Crossmark Global Holdings Inc. raised its stake in shares of Teleflex by 1.9% in the second quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock worth $584,000 after purchasing an additional 53 shares during the last quarter. KBC Group NV boosted its position in Teleflex by 1.8% in the fourth quarter. KBC Group NV now owns 3,173 shares of the medical technology company’s stock valued at $791,000 after buying an additional 55 shares during the last quarter. Empirical Finance LLC increased its holdings in Teleflex by 3.9% in the 1st quarter. Empirical Finance LLC now owns 1,564 shares of the medical technology company’s stock worth $354,000 after buying an additional 58 shares during the period. Finally, SRS Capital Advisors Inc. raised its position in Teleflex by 0.3% during the 2nd quarter. SRS Capital Advisors Inc. now owns 19,527 shares of the medical technology company’s stock worth $4,107,000 after buying an additional 62 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Insider Transactions at Teleflex

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of Teleflex stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the transaction, the director now directly owns 5,496 shares in the company, valued at approximately $1,313,159.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.43% of the company’s stock.

Analyst Ratings Changes

TFX has been the topic of several analyst reports. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $205.00 to $245.00 in a research report on Monday, July 1st. Truist Financial increased their target price on Teleflex from $240.00 to $247.00 and gave the company a “hold” rating in a report on Monday, August 5th. Royal Bank of Canada boosted their price target on Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Finally, Stephens raised their price objective on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $265.57.

Teleflex Trading Up 1.0 %

NYSE TFX opened at $244.87 on Tuesday. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $257.85. The stock has a market capitalization of $11.53 billion, a P/E ratio of 39.30, a PEG ratio of 2.23 and a beta of 1.16. The firm’s 50-day moving average is $235.85 and its two-hundred day moving average is $220.59. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.09. The firm had revenue of $749.70 million during the quarter, compared to the consensus estimate of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The firm’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter last year, the firm earned $3.41 EPS. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.97 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Thursday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.56%. The ex-dividend date was Thursday, August 15th. Teleflex’s payout ratio is currently 21.83%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.